In This Section
Issues & Advocacy
SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.
LATEST NEWS
- September 17, 2014 —
Update on Kinevac Availability
Bracco Diagnostics Inc. announced that production is moving forward with targeted efforts for Kinevac commercial availability by the end of September. - August 20, 2014 —
Upcoming Webinar: Oncologic PET Coding & Reimbursement
On September 23, 2014, Merlino Health Care Consulting Corp. will hold the webinar "Oncologic PET Coding & Reimbursement, Where Are We Today?" - August 13, 2014 —
NTP to Resume Normal Operations
NTP Radioisotopes has received approval to resume normal operations. - July 24, 2014 —
Scheduled NTP Shutdown Moved Up
Recently, NTP Radioisotopes experienced a minor operational incident at their manufacturing facility, and their Nuclear Regulator instructed them to not proceed with any operation until they had the opportunity to review the situation. NTP moved up their scheduled two week maintenance period to minimize the impact of the current situation. - July 15, 2014 —
Technetium Tc99m Exametazime Injection (Ceretec Kit) Shortage
On July 14, 2014, FDA announced a shortage of Technetium Tc99m Exametazime Injection (Ceretec Kit). - July 3, 2014 —
CMS Releases CY 2015 Hospital Outpatient Prospective Payment System Proposed Rule
On July 3, 2014, CMS released the CY 2015 HOPPS proposed rule. - July 3, 2014 —
CMS Releases CY 2015 Medicare Physician Fee Schedule Proposed Rule
On July 3, 2014, CMS issued a proposed rule that would update payment policies and payment rates for services furnished under the MPFS on or after Jan. 1, 2015. - July 1, 2014 —
CMS Releases Instructions Related to the NCD to End the Coverage with Evidence Development Requirement for FDG PET for Solid Tumors
CMS has released instructions to Medicare Administrative Contractors regarding the processing of claims pursuant to the June 11, 2013 final decision to end the coverage with evidence development (CED) requirement for certain FDG PET studies for solid tumors.
Click For More Government Relations News
HPRA NEWSLETTER
-
Central Chapter
The Central Chapter of SNMMI. -
Missouri Valley Chapter
The Missouri Valley Chapter of SNMMI. -
Patients and Survivors
Videos of Patients and Survivors for the Patients Audience Page